-
Product Insights
NewLikelihood of Approval Analysis for Acquired (Autoimmune) Hemolytic Anemia
Overview How likely is it that the drugs in Acquired (Autoimmune) Hemolytic Anemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acquired (Autoimmune) Hemolytic Anemia Overview Acquired autoimmune hemolytic anemia (AIHA)...
-
Product Insights
NewLikelihood of Approval Analysis for Drug Toxicity
Overview How likely is it that the drugs in Drug Toxicity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Drug Toxicity Overview Drug toxicity' can be defined as a diverse array...
-
Product Insights
NewLikelihood of Approval Analysis for Type I Hypersensitivity
Overview How likely is it that the drugs in Type I Hypersensitivity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Type I Hypersensitivity Overview Type 1 hypersensitivity is a type of...
-
Product Insights
NewLikelihood of Approval Analysis for Hormone Sensitive Breast Cancer
Overview How likely is it that the drugs in Hormone Sensitive Breast Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hormone Sensitive Breast Cancer Overview Estrogen and progesterone promote the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CAMH-2 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAMH-2 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAMH-2 in Gastric Cancer Drug Details: CAMH-2 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CAMH-2 in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAMH-2 in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAMH-2 in Gastroesophageal (GE) Junction Carcinomas Drug Details: CAMH-2 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SON-1010 in Mesenchymal Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SON-1010 in Mesenchymal Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SON-1010 in Mesenchymal Tumor Drug Details: SON-1010 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – FS-102 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FS-102 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FS-102 in Gastric Cancer Drug Details: FS-102 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – FS-102 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FS-102 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FS-102 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – FS-102 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FS-102 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FS-102 in...